Update on efficacy of the approved remdesivir regimen for treatment of COVID-19: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Update on efficacy of the approved remdesivir regimen for treatment of COVID-19: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials

Published:2024-06-19 Issue:8 Volume:40 Page:1277-1287
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Okoli George N.¹²,Reddy Viraj K.¹,Lam Otto LT.¹,Askin Nicole³,Rabbani Rasheda¹

Affiliation:

1. George and Fay Yee Centre for Healthcare Innovation, Max Rady College of Medicine, , University of Manitoba, Winnipeg, Canada

2. College of Pharmacy, University of Manitoba, Winnipeg, Canada

3. Neil John Maclean Health Sciences Library, University of Manitoba, Winnipeg, Canada

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2366443

Reference44 articles.

1. World Health Organization. R&D Blueprint and COVID-19. The World Health Organization; 2021. https://bit.ly/3rmQRCw. Accessed January 12.

2. United States Food and Drug Administration. NDA 214787: cross Discipline Team Leader Division Director and ODE Director Summary Review. United States Food and Drug Administration; 2020. https://bit.ly/2TiAYOz. Accessed October 23.

3. Remdesivir against COVID-19 and Other Viral Diseases

4. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

5. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP